Holen Sie sich die Stockscreener-App
67.16
3.06%
-2.12
Handel nachbörslich:
67.16
Schlusskurs vom Vortag:
$69.28
Offen:
$69.53
24-Stunden-Volumen:
1.14M
Relative Volume:
0.64
Marktkapitalisierung:
$3.57B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-22.41
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
+4.64%
1M Leistung:
-0.65%
6M Leistung:
-10.29%
1J Leistung:
+21.98%
1-Tages-Spanne:
$66.75
$69.59
1-Wochen-Bereich:
$64.90
$72.80
52-Wochen-Spanne:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
Soleno Therapeutics Inc
Sektor
Branche
Telefon
650-213-8444
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Vergleichen Sie SLNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
67.16 | 3.68B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Eingeleitet | Goldman | Buy |
| 2025-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-23 | Eingeleitet | TD Cowen | Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2024-12-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-12-02 | Bestätigt | Stifel | Buy |
| 2024-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-23 | Eingeleitet | Stifel | Buy |
| 2023-11-21 | Fortgesetzt | Guggenheim | Buy |
| 2020-09-29 | Eingeleitet | Guggenheim | Buy |
| 2020-01-10 | Eingeleitet | Craig Hallum | Buy |
| 2019-12-23 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
How moving averages guide Soleno Therapeutics Inc. tradingTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Will Soleno Therapeutics Inc. stock reach Wall Street targetsMarket Activity Report & Daily Profit Focused Stock Screening - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingWatch List & Verified Short-Term Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersEntry Point & Precise Buy Zone Identification - newser.com
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Has Soleno Therapeutics Inc. formed a bullish divergenceBull Run & Risk Controlled Stock Pick Alerts - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Strategies to average down on Soleno Therapeutics Inc.July 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Bluefield Daily Telegraph
Soleno Therapeutics (SLNO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Soleno Therapeutics, Inc. $SLNO is Emerald Advisers LLC's 6th Largest Position - MarketBeat
Soleno Therapeutics Stock Jumped 5.2% in a Day, What Now? - Trefis
What analysts say about Soleno Therapeutics Inc stockGap Up/Gap Down Analysis & Never Miss the Next Wealth Opportunity - earlytimes.in
Soleno Therapeutics to Participate in Upcoming November Conferences - The Manila Times
Soleno Therapeutics (NASDAQ: SLNO) sets November talks at Guggenheim and Jefferies - Stock Titan
Published on: 2025-10-27 22:15:31 - newser.com
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Published on: 2025-10-27 17:52:32 - newser.com
How Soleno Therapeutics Inc. stock performs after earningsJuly 2025 Selloffs & Weekly High Return Opportunities - fcp.pa.gov.br
What data driven models say about Soleno Therapeutics Inc.’s futureInsider Buying & Safe Capital Investment Plans - newser.com
Published on: 2025-10-27 15:50:22 - newser.com
Will Soleno Therapeutics Inc. stock gain from strong economyLayoff News & Community Verified Trade Signals - fcp.pa.gov.br
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):